Prognostic significance of variables in the univariate analysis
| Variable included | Regression coefficient (β) | p Coefficient | |
| 1 | Bilirubin (<2 mg/dl) | 0.644192 | 0.000016 |
| 2 | PT (<70%) | 0.621770 | 0.000077 |
| 3 | Ascites (yes-no) | 0.591207 | 0.000126 |
| 4 | Albumin (<3.5g/dl) | 0.507730 | 0.000635 |
| 5 | PVT | 0.545117 | 0.000901 |
| 6 | AFP (<125 kU/l) | 0.475678 | 0.001034 |
| 7 | Enlarged lymph nodes | 0.495509 | 0.001757 |
| 8 | Distant metastases | 0.492607 | 0.002174 |
| 9 | Unilobar/bilobar | −0.005126 | 0.025371 |
| 10 | Tumour >50% (yes-no) | 0.318607 | 0.026102 |
| 11 | Diameter (>2 cm) | −0.005125 | 0.029782 |
| 12 | No of tumour nodules | −0.004821 | 0.039713 |
| 13 | Edmondson-Steiner | 0.223954 | 0.079851 |
| 14 | HBV (HBsAg+) | 0.363311 | 0.109207 |
| 15 | Age | 0.010530 | 0.127132 |
| 16 | Smoking | 0.227728 | 0.149910 |
| 17 | Sex | −0.081306 | 0.631941 |
| 18 | Alcohol | 0.000294 | 0.835254 |
| 19 | HCV (anti-HCV+) | 0.006705 | 0.963396 |
HCV, hepatitis C virus; HBV, hepatitis B virus; HBsAg, hepatitis B virus surface antigen; PTV, portal vein thrombosis; PT, prothrombin time; AFP, α fetoprotein.